Abstract
These studies report on the activation and induction of cGMP-dependent protein kinase (PKG) by exisulind and analogs and test the hypothesis that PKG is involved in the induction of apoptosis in colon tumor cells. Exisulind and analogs are proapoptotic drugs developed as inhibitors of cGMP phosphodiesterase gene families 5 and 2 that have been shown to sustain increased cGMP in SW480 and HT29 cells. At concentrations that induced apoptosis, both exisulind and CP461 increased PKG activity in SW480 cell supernatants. PKG activation was dose-dependent and sustained. Activation of PKG by exisulind and analogs was also seen in the colon tumor cell lines HT29, T84, and HCT116. The guanylyl cyclase activators YC-1 and guanylin increased PKG activity secondary to increased cellular cGMP and induced apoptosis in colon tumor cells. Exisulind and CP461 had no direct effect on purified PKG activity or on basal and stimulated PKG activity from cell supernatants. An additional effect of exisulind after 8 h of drug treatment was a dose-dependent increase of PKG Iβ protein expression. β-Catenin, a potential new substrate for PKG, whose regulation influences apoptosis, was phosphorylated by PKG in vitro.32P-labeled cells treated with exisulind showed increased phosphorylation of β-catenin. These data indicate that exisulind and analogs activate and induce PKG, resulting in increased phosphorylation of β-catenin and enhanced apoptosis to promote colon tumor cell death.
Footnotes
-
This work was supported by Cell Pathways Inc. and in part by National Institutes of Health Grant HL46494 (to W.J.T.). Part of these data have been presented at the 91st American Association of Cancer Research (San Francisco, CA) in abstract form.
- Abbreviations:
- GC
- guanylyl cyclase
- PDE
- phosphodiesterase
- YC-1
- 3-(5′-hydroxymethyl-2′-furyl)-benzylindazole
- JNK1
- c-Jun NH2-terminal kinase 1
- PKG
- cGMP-dependent protein kinase
- APC
- adenomatous polyposis coli
- 8-Br-cGMP
- 8-bromo-cGMP
- FSK
- forskolin
- GSH
- glutathione
- GST
- glutathione S-transferase
- PKA
- cAMP-dependent protein kinase
- PKI
- protein kinase A inhibitor 5-24
- DMSO
- dimethyl sulfoxide
- RT-PCR
- reverse transcriptase-polymerase chain reaction
- WT
- wild-type
- PAGE
- polyacrylamide gel electrophoresis
- PBS
- phosphate-buffered saline
- ELISA
- enzyme-linked immunosorbent assay
- SAAND
- selective apoptotic antineoplastic drug
- MEKK1
- mitogen-activated protein kinase kinase kinase-1
- Received March 12, 2001.
- Accepted July 27, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|